Luye Pharma’s New Antipsychotic Drug LY03020 Approved for U.S. Clinical Trials
PremiumCompany AnnouncementsLuye Pharma’s New Antipsychotic Drug LY03020 Approved for U.S. Clinical Trials
3M ago
Luye Pharma Chairman Increases Stake, Signals Confidence
Premium
Company Announcements
Luye Pharma Chairman Increases Stake, Signals Confidence
4M ago
Luye Pharma Announces Convertible Bond Issuance
Premium
Company Announcements
Luye Pharma Announces Convertible Bond Issuance
4M ago
Luye Pharma’s $100 Million Convertible Bonds Issuance
PremiumCompany AnnouncementsLuye Pharma’s $100 Million Convertible Bonds Issuance
5M ago
Luye Pharma Boosts Liquidity with $100M Bond Issue
Premium
Company Announcements
Luye Pharma Boosts Liquidity with $100M Bond Issue
5M ago
Luye Pharma Adjusts Closing Date for Bond Issue
Premium
Company Announcements
Luye Pharma Adjusts Closing Date for Bond Issue
5M ago
Luye Pharma’s Breakthrough Drug Enters Clinical Trials
PremiumCompany AnnouncementsLuye Pharma’s Breakthrough Drug Enters Clinical Trials
8M ago
Luye Pharma’s ERZOFRI Wins FDA Approval
Premium
Company Announcements
Luye Pharma’s ERZOFRI Wins FDA Approval
8M ago
Luye Pharma Group Announces Major Investment Deal
Premium
Company Announcements
Luye Pharma Group Announces Major Investment Deal
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100